Curta leadership will be attending the World Evidence, Pricing, and Access (EPA) Congress in Amsterdam on March 5-6, 2025—Europe’s largest event dedicated to market access, pricing, and evidence in healthcare.
With over 300 speakers, 1,500+ delegates, and 120+ exhibitors, this year’s event will feature discussions across nine key tracks, including Market Access, HTA, HEOR, Rare Diseases, and Real-World Evidence. The 2025 edition introduces a dedicated HEOR track and a poster area for deeper understanding of how HEOR can support market access, making it a must-attend for industry leaders navigating the future of evidence generation and payer expectations.
We’re excited to participate in conversations shaping pricing, reimbursement, and market access strategies in Europe and the U.S..
🚀 Still a few meeting spots open! If you’d like to connect, reach out to schedule a time.
